Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue for treatment of hospitalized adults with severe COVID-19
IRCT20211012052735N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methylene blue in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
methylene blue
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20211012052735N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211012052735N1.